Breast Cancer
For patients, economic burden of cancer care exceeds $21 billion
The economic burden of cancer care in the United States remained heavy for patients, who incurred more than $21 billion in costs in 2019, according to part two of the Annual Report to the Nation on the Status of Cancer.
10 important updates in breast cancer treatment, survivorship
Breast Cancer Awareness Month, observed every October, is an international campaign designed to increase awareness of the disease and raise money to fund research for prevention, earlier detection and more effective treatment.
Personalized approach to radiation therapy predicts efficacy across cancer types
A personalized approach to radiation therapy can maximize therapeutic effect across multiple cancer types, according to findings published in The Lancet Oncology.
Elacestrant extends PFS in advanced breast cancer
A randomized phase 3 trial designed to evaluate elacestrant for patients with ER-positive, HER2-negative advanced or metastatic breast cancer met both of its primary endpoints, according to the agent’s manufacturer.
Earlier breast cancer screening for Black women could reduce mortality disparities
Establishing biennial mammography screening beginning at age 40 years could reduce breast cancer-associated mortality by 57% among Black women, according to study results published in Annals of Internal Medicine.
Nut consumption associated with survival benefit among long-term breast cancer survivors
Nut consumption appeared associated with higher survival rates among long-term breast cancer survivors and should be emphasized as a modifiable lifestyle factor in survivor guidelines, according to a study in International Journal of Cancer.
Many patients with breast cancer use cannabis but do not notify their physician
More than 40% of patients with breast cancer reported using cannabis to manage their treatment symptoms, yet most patients did not discuss cannabis use with a physician, according to survey results published in Cancer.
FDA approves Verzenio for certain patients with early breast cancer
The FDA approved abemaciclib in combination with endocrine therapy for adjuvant treatment of certain patients with early breast cancer.
Adjuvant platinum-based chemotherapy fails to improve outcomes in breast cancer subset
Platinum-based chemotherapy after neoadjuvant chemotherapy did not improve outcomes compared with capecitabine among patients with basal subtype triple-negative breast cancer and residual invasive disease, according to study results.
Sexual dysfunction due to breast cancer care improves with nonhormonal treatments
Safe and effective treatments are available for women who experience sexual dysfunction because of breast cancer care, according to a presentation during the NAMS Annual Meeting.